Document Detail

Clinicopathologic features of brain metastases from gynecologic malignancies: A retrospective study of 139 cases (KCOG-G1001s trial).
MedLine Citation:
PMID:  23142074     Owner:  NLM     Status:  Publisher    
OBJECTIVE: Although brain metastases from gynecologic malignancies are rare, such cases have been gradually increasing in number. The aim of the present study was to evaluate the clinicopathologic features and prognostic factors of brain metastases from gynecologic malignancies. METHODS: Retrospective analysis of 139 patients with brain metastases from gynecologic malignancies was carried out as a multi-institutional study. The clinicophathological data of the patients were collected from medical records. RESULTS: Median survival time of the patients with brain metastases was 12.5months for the ovarian cancer group, 6.2months for the corpus cancer group, and 5.0months for the cervical cancer group; two-year overall survival rates were 19.7%, 6.1%, and 4.8%, respectively. Multivariate analysis revealed ovarian/tubal/peritoneal origin, KPS >70, single brain metastasis, absence of extracranial disease, cranial surgery, cranial radiotherapy, and chemotherapy to be independent favorable prognostic factors associated with overall survival. CONCLUSION: It is considered that aggressive multimodal therapy is warranted in the treatment of brain metastases from gynecologic malignancies in carefully selected patients. The present study may provide a platform for the discussion of management strategies in these rare clinical scenarios.
Kaei Nasu; Toyomi Satoh; Shin Nishio; Yutaka Nagai; Kimihiko Ito; Takeo Otsuki; Atsushi Hongo; Yasuyuki Hirashima; Tomonori Ogura; Muneaki Shimada
Related Documents :
7696164 - Combined-modality treatment of small-cell lung cancer: randomized comparison of three i...
24630774 - Is primary tumor resection associated with a longer survival in colon cancer and unrese...
6894814 - Chemotherapy of carcinoma of renal pelvis: preliminary report.
6401594 - A randomized comparison of melphalan versus melphalan plus hexamethylmelamine versus ad...
17039404 - Phase ii study of amrubicin in previously untreated patients with extensive-disease sma...
10606174 - Prognostic relevance of tp53 mutations, p53 protein, ki-67 index and conventional histo...
Publication Detail:
Type:  JOURNAL ARTICLE     Date:  2012-11-8
Journal Detail:
Title:  Gynecologic oncology     Volume:  -     ISSN:  1095-6859     ISO Abbreviation:  Gynecol. Oncol.     Publication Date:  2012 Nov 
Date Detail:
Created Date:  2012-11-12     Completed Date:  -     Revised Date:  -    
Medline Journal Info:
Nlm Unique ID:  0365304     Medline TA:  Gynecol Oncol     Country:  -    
Other Details:
Languages:  ENG     Pagination:  -     Citation Subset:  -    
Copyright Information:
Copyright © 2012. Published by Elsevier Inc.
Kansai Clinical Oncology Group (KCOG), Osaka, Osaka 543-8555, Japan; Department of Obstetrics and Gynecology, Faculty of Medicine, Oita University, Yufu-shi, Oita 879-5593, Japan. Electronic address:
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine

Previous Document:  First report of the use of a saxitoxin-protein conjugate to develop a DNA aptamer to a small molecul...
Next Document:  The Prognostic Value of Vascular Endothelial Growth Factor in Ovarian Cancer: A Systematic Review an...